Last reviewed: June 23, 2026

Last updated: June 23, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Wegovy injection is a prescription medication containing semaglutide, the same active ingredient found in the diabetes drug Ozempic. Semaglutide works by mimicking glucagon-like peptide-1 (GLP-1), a natural hormone that regulates blood sugar and appetite. Understanding what makes up this injection helps patients make informed decisions about weight loss treatment options.

What is Semaglutide and How Does It Work

Semaglutide is a synthetic peptide that activates GLP-1 receptors throughout the body. When injected, it binds to receptors in the pancreas, brain, and gastrointestinal tract to produce three key effects: it signals fullness to the brain, slows the rate at which food moves from your stomach into your small intestine, and helps the pancreas release insulin when blood sugar rises. Clinical trials show patients using semaglutide reduce food intake by approximately 25-35% within the first month of treatment.

The medication was originally developed by Novo Nordisk for type 2 diabetes management under the brand name Ozempic. Recognizing its powerful weight loss effects, the company created Wegovy as a higher-dose formulation specifically for chronic weight management in adults with obesity or overweight conditions and at least one weight-related health problem. The active compound remains identical across both products; only the approved indication differs.

Active and Inactive Ingredients in Wegovy Injection

Each Wegovy prefilled pen contains semaglutide as the active ingredient, suspended in a sterile solution with sodium chloride, sodium phosphate dibasic dihydrate, sodium phosphate monobasic dihydrate, and water for injection. These inactive components maintain the medication's stability, pH balance, and sterility throughout its shelf life. The solution is isotonic, meaning it has the same salt concentration as human blood, which minimizes injection site irritation and discomfort.

Wegovy pens do not contain any animal-derived ingredients, making them suitable for most patients regardless of dietary restrictions. The formulation is preservative-free in single-dose pens, which reduces the risk of allergic reactions or irritation. Each 0.25 mL, 0.5 mL, 1.0 mL, or 2.0 mL dose delivers a precise amount of semaglutide, allowing doctors to tailor therapy to individual patient needs and tolerance.

Compounded Semaglutide vs Brand-Name Wegovy

Compounded semaglutide contains the identical active compound as Wegovy but is manufactured by licensed 503A compounding pharmacies rather than large pharmaceutical manufacturers. The FDA does not pre-approve compounded medications the way it does brand-name drugs, but 503A compounders operate under strict state and federal regulations, including regular sterility and potency testing. PlexusDx partners exclusively with licensed 503A compounding pharmacies to ensure quality and safety standards are met.

The primary difference between compounded and brand-name semaglutide lies in cost and delivery method. Wegovy typically costs $900-$1,300 per month through insurance or cash pay, while PlexusDx compounded semaglutide injection starts at $149 per month. Both formulations work through the same biological mechanism, and real-world outcomes data shows comparable weight loss results between compounded and brand-name GLP-1 products when dosed appropriately.

Personalized Treatment With Precision Peptide Genetic Testing

PlexusDx offers the Precision Peptide Genetic Test, a peptide-pathway analysis (not pharmacogenomic) that examines how your body's genetic makeup influences response to semaglutide and other GLP-1 therapies. The test evaluates key variants including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313, which affect appetite regulation, insulin secretion, and metabolic rate. By mapping 14 distinct pathways and 150+ genetic insights, PlexusDx can help identify which formulation—semaglutide, tirzepatide, or dual-compound therapy—may produce the best outcomes for your body.

Patients beginning their first month of treatment can add the Precision Peptide Genetic Test for $99, providing actionable data that informs dose titration and medication selection. This personalized approach reduces trial-and-error prescribing and may accelerate weight loss results compared to standard dosing protocols. The test is particularly valuable for patients who have tried GLP-1 therapy previously and did not achieve expected results.

Safety, Side Effects, and Storage Considerations

Common side effects of semaglutide include nausea, vomiting, constipation, and diarrhea, typically occurring during dose escalation phases and resolving as the body adjusts. Serious but rare adverse events include pancreatitis, gallbladder problems, and thyroid concerns; patients with personal or family history of medullary thyroid carcinoma should not use GLP-1 medications. PlexusDx requires a comprehensive health history and consultation before dispensing any compounded semaglutide to screen for contraindications.

Semaglutide injections must be stored in the refrigerator between 2°C and 8°C (36°F and 46°F) before first use and can remain at room temperature (below 30°C) for up to 30 days once the pen is opened. Patients should never freeze the medication or expose it to direct sunlight. All injectable semaglutide—whether brand-name or compounded—uses the same storage and handling guidelines to maintain potency and safety.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is compounded semaglutide from PlexusDx the same active ingredient as Wegovy?

Yes, PlexusDx compounded semaglutide injection contains the identical active compound as Wegovy, manufactured through licensed 503A compounding pharmacies under strict quality standards. The key difference is cost: PlexusDx starts at $149 per month compared to $900-$1,300 for brand-name Wegovy, with the same biological mechanism of action.

How much weight can I expect to lose with semaglutide injection?

Clinical trials show patients using semaglutide lose 12-22% of body weight over 68 weeks, depending on dose and individual factors. Real-world data from PlexusDx patients report similar results, with weight loss beginning within 4-6 weeks of consistent treatment. Genetic factors, diet adherence, and activity level significantly influence individual outcomes.

Does PlexusDx require insurance or membership fees?

No, PlexusDx serves all 50 states without insurance requirements or membership fees. Compounded semaglutide injection starts at $149 per month and is HSA/FSA eligible, making personalized weight loss therapy accessible to most patients regardless of insurance status.

What are the most common side effects of semaglutide injection?

Nausea, vomiting, constipation, and diarrhea are common during the first 2-4 weeks as your body adjusts to the medication. These effects typically resolve with continued use and dose stabilization. Serious side effects like pancreatitis are rare but require immediate medical attention if symptoms develop.

How does the Precision Peptide Genetic Test improve my semaglutide treatment?

PlexusDx Precision Peptide Genetic Test analyzes 49 peptides across 14 pathways to identify your genetic predispositions for GLP-1 response, including variants in GLP1R, GIPR, FTO, and MC4R genes. This testing guides optimal medication selection and dosing strategy, potentially accelerating weight loss and reducing side effects compared to standard dosing alone.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves